Evogene Ltd.
EVGN · XNASCIK 1574565fmd_1WS00FBST24K949T2ZBYZAG651Manufacturing · Agricultural ChemicalsTemplate: Standard
Coverage: Jan 01, 2015 to Dec 31, 2025, 18 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 | 3 | 2 | 1 | 1 | 1 | 2 | 3 | 6 | 4 |
| Cost of revenue | 6 | 3 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 4 |
| Gross profit | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | (0) |
| Research and development | 16 | 17 | 15 | 16 | 17 | 21 | 21 | 16 | 13 | 8 |
| Selling, general and administrative | 4 | 4 | 4 | 4 | 5 | 7 | 6 | 5 | 7 | 4 |
| Operating income | (21) | (22) | (20) | (21) | (25) | (31) | (27) | (22) | (19) | (14) |
| Interest expense | 1 | 1 | 2 | 1 | 3 | 1 | 3 | 1 | 3 | 2 |
| Income before taxes | (20) | (21) | (21) | (19) | (26) | (30) | (30) | (22) | (15) | (13) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (20) | (21) | (21) | (19) | (26) | (30) | (30) | (22) | (15) | (13) |
| Net income | (20) | (21) | (21) | (18) | (23) | (28) | (27) | (24) | (16) | (8) |